SRL
KYMR icon

Scientech Research LLC’s Kymera Therapeutics KYMR Stock Holding History

Scientech Research LLC’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Buy
+12,943
New +$1.11M 1.2% 24
2026
Q1 		– Sell
-7,379
Closed -$574K – 615
2025
Q4 		$574K Buy
+7,379
New +$498K 0.36% 65
2024
Q2 		– Sell
-11,572
Closed -$465K – 663
2024
Q1 		$465K Buy
+11,572
New +$414K 0.25% 180

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Scientech Research LLC's KYMR Position: Q2 2026 in Review

Scientech Research LLC opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 12,943 shares worth $1.48M. The stake represents 1.2% of the portfolio and ranks #24 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in KYMR as recently as Q4 2025.

Scientech Research LLC first reported a position in KYMR in Q1 2024 and has held it in 3 quarters since. 277 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Scientech Research LLC held 12,943 shares of Kymera Therapeutics worth $1.48M as of Q2 2026.
  • Kymera Therapeutics was a new Scientech Research LLC position in Q2 2026.
  • Kymera Therapeutics made up 1.2% of Scientech Research LLC's portfolio in Q2 2026, its #24 holding.
  • Scientech Research LLC first reported a position in Kymera Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • 277 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.